DOCSLIB.ORG

Supplementary Table S1: List of Validated Hits from N Minus RAS Screen

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table S1: List of Validated Hits from N Minus RAS Screen Supplementary Table S1: List of validated hits from N minus RAS screen Entrez Gene S.N. Gene ID 1 Methyl CpG Binding Protein 2 (MECP2) 4204 2 Orthodenticle Homeobox 2 (OTX2) 5015 3 Target Of Myb1 (Chicken) (TOM1) 10043 4 G Protein-Coupled Receptor 171 (GPR171) 29909 5 Flotillin 2 (FLOT2) 2319 6 Chromosome 12 Open Reading Frame 74 (C12ORF74) 338809 7 Histone Cluster 1, H2bn (HIST1H2BN) 8341 8 Histone Cluster 1, H3f (HIST1H3F) 8968 9 Solute Carrier Family 25, Member 41 (SLC25A41) 284427 10 Chimerin 1 (CHN1) 1123 11 Zinc Finger Protein 658 (ZNF658) 26149 12 Lipoxygenase Homology Domains 1 (LOXHD1) 125336 13 Regulator Of G-Protein Signaling 3 (RGS3) 5998 14 Chloride Channel, Voltage-Sensitive Kb (CLCNKB) 1188 15 Calmodulin 3 (Phosphorylase Kinase, Delta) (CALM3) 808 Supplementary Table S2: Amplicons in Human Cancer (from Broad Institute TCGA Copy Number Portal) #Genes Residual Q- High- Peak Region in Peak value Overall Focal level chr7:55065906-55102668 1 0 0.382 0.068 0.084 chr8:128739771-128769210 1 1.74E-272 0.453 0.129 0.139 chr11:69460105-69484581 2 2.12E-222 0.208 0.106 0.065 chr17:37855834-37875909 1 1.22E-204 0.199 0.054 0.038 chr19:30306820-30315735 1 5.49E-183 0.24 0.066 0.055 chr12:69212831-69260428 2 1.07E-144 0.211 0.053 0.04 chr3:169416569-169490229 2 2.03E-124 0.335 0.118 0.093 chr12:58135796-58155222 6 3.76E-122 0.205 0.045 0.033 chr11:70140426-70213455 1 5.18E-118 0.204 0.102 0.062 chr1:150519259-150703005 8 3.65E-113 0.37 0.1 0.078 chr3:181256573-181731927 3 9.82E-81 0.328 0.118 0.089 chr11:77613200-77640847 1 1.45E-78 0.169 0.068 0.031 chr8:38171486-38254058 2 2.04E-71 0.234 0.067 0.057 chr5:1288615-1299329 1 1.40E-60 0.317 0.071 0.076 chr4:55008314-55104469 1 1.46E-51 0.114 0.05 0.023 chr12:25344325-25370603 3 2.82E-44 0.245 0.041 0.047 chr8:41761807-41929152 1 4.94E-41 0.259 0.06 0.055 chr15:99056932-99774542 6 2.14E-37 0.145 0.064 0.018 chr1:204353015-204538342 3 1.58E-36 0.363 0.046 0.066 chr12:889902-1041097 12 9.28E-34 0.247 0.058 0.043 chr20:30203029-30315025 2 9.01E-33 0.391 0.045 0.073 chr1:40377907-40416849 0 7.80E-29 0.145 0.051 0.018 chr1:242980673-247812431 84 1.22E-28 0.352 0.072 0.06 chr19:39770395-39892270 9 1.27E-28 0.217 0.043 0.035 chr17:57922442-57943519 1 1.34E-27 0.242 0.048 0.029 chrX:153016891-153342426 18 1.21E-26 0.176 0.059 0.018 (MECP2 containing amplicon) chr7:92173409-92556768 4 8.22E-26 0.363 0.039 0.05 chr1:160989893-161115583 9 2.07E-25 0.369 0.077 0.069 chr8:101324125-101642253 4 9.37E-25 0.417 0.061 0.104 chr20:52156927-52364760 2 3.87E-24 0.401 0.043 0.083 chr8:37492872-37529770 0 1.51E-23 0.223 0.059 0.051 chr6:43638636-43987936 5 1.62E-21 0.197 0.043 0.027 chr3:197077908-197335218 1 2.59E-21 0.315 0.112 0.078 chr13:113757997-114302622 13 1.20E-19 0.179 0.058 0.03 chr11:102266643-102488711 3 1.99E-19 0.134 0.035 0.019 chr17:27148617-27422161 14 1.97E-18 0.185 0.048 0.018 chr20:62187416-62219648 39 1.61E-17 0.397 0.056 0.079 chr19:15338573-15408584 2 1.95E-17 0.194 0.04 0.028 chr14:36544027-37264674 9 2.45E-15 0.144 0.043 0.019 chr6:20396454-20522290 1 1.01E-14 0.205 0.037 0.029 chr8:144939389-145147978 12 1.55E-14 0.424 0.105 0.108 chr9:35654478-35737197 10 1.99E-13 0.138 0.044 0.019 chr11:66980818-67054144 3 2.88E-13 0.176 0.072 0.022 chr4:1778801-1816690 2 2.44E-12 0.107 0.042 0.016 chr18:20358314-20503269 1 1.35E-11 0.143 0.036 0.022 chr17:73466243-73637996 8 6.82E-11 0.258 0.07 0.027 chr6:107198296-107289865 2 1.13E-09 0.105 0.024 0.015 chr11:34639284-34838823 1 1.69E-09 0.127 0.033 0.014 chr10:76501637-77227430 10 2.01E-09 0.107 0.035 0.013 chr2:178085599-178160931 4 1.47E-08 0.163 0.043 0.013 chr8:80714469-81835247 5 3.48E-08 0.385 0.041 0.082 chr17:77765982-77821663 3 5.70E-07 0.256 0.072 0.024 chr5:37909815-44676519 52 5.95E-07 0.288 0.038 0.061 chr4:73903374-74158212 2 1.78E-06 0.095 0.039 0.014 chr14:105197567-105318962 7 2.49E-06 0.14 0.045 0.013 chr22:18613737-22139416 90 3.08E-06 0.14 0.038 0.014 chr19:55547934-58878226 147 5.70E-06 0.192 0.045 0.017 chr8:55091227-55382067 1 8.28E-06 0.349 0.045 0.067 chr6:64084316-64402884 2 1.45E-05 0.153 0.038 0.015 chr12:66217394-66241372 2 1.58E-05 0.197 0.037 0.026 chr5:176445948-176904216 15 1.60E-05 0.166 0.052 0.015 chr9:4894234-5591850 8 2.00E-05 0.126 0.03 0.019 chr19:35494834-36225620 37 4.83E-05 0.229 0.047 0.035 chr14:20501368-21697941 66 7.10E-05 0.144 0.049 0.014 chr19:10238547-10877387 28 2.28E-04 0.176 0.034 0.021 chr7:146690968-158383607 112 5.87E-04 0.339 0.045 0.04 chr17:48773492-49002559 7 9.47E-04 0.218 0.031 0.02 chr10:5507029-5769453 4 0.003 0.167 0.037 0.022 chr13:73907772-73972011 0 0.00339 0.156 0.031 0.029 chr7:708774-1243749 22 0.00349 0.375 0.046 0.045 chr6:11203906-11588708 2 0.00387 0.203 0.043 0.026 chr2:60243955-63176269 21 0.0124 0.193 0.031 0.014 chr3:13669693-13758663 2 0.0347 0.115 0.033 0.01 chr8:115442722-118152629 9 0.0752 0.43 0.083 0.109 chr9:139822542-140366608 44 0.0981 0.143 0.043 0.011 chr2:113962850-114139862 2 0.102 0.16 0.034 0.011 chr10:123172835-123398895 1 0.117 0.096 0.029 0.009 chr13:27260341-28888798 23 0.146 0.135 0.031 0.023 chr7:116314195-116508848 2 0.156 0.346 0.027 0.041 Note: Q values (False Discovery Values) below 0.25 are considered significant Supplementary Table S3: Cancer cell lines used in current study with their MECP2 expression and RAS/MAPK/PI3K pathways mutation status (based on COSMIC, canSAR, ATCC, and CCLE databases) RAS Other relevant mutations Cell lines mutation (in MAPK and PI3K pathways) BREAST MECP2 overexpressing cell lines: BT549 Wild-type PTENV275X MDAMB468 Wild-type PTENA72fsX5 MDAMB453 Wild-type PTENE307K; PIK3CAH1047R BT20 Wild-type PIK3CAP539R; PIK3CAH1047R MCF7 Wild-type PIK3CAE545K Cell lines with low MECP2: ZR75-1 Wild-type PTENL108R MDAMB231 KRASG13D BRAFG464V; NF2E231* T47D Wild-type PIK3CAH1047R HCC38 Wild-type LUNG MECP2 overexpressing cell lines: NCI-H1755 Wild-type BRAFG468A NCI-H23 KRASG12C NCI-H1993 Wild-type MET amplification NCI-H2228 Wild-type EML4-ALK fusion NCI-H2170 Wild-type NCI-H2009 KRASG12A NCI-H522 Wild-type NCI-H1563 Wild-type Cell lines with low MECP2: NCI-H1437 Wild-type NCI-H1395 Wild-type BRAFG469A NCI-H838 Wild-type NCI-H2347 NRASQ61R OVARIAN MECP2 overexpressing cell lines: EFO21 Wild-type IGROV1 Wild-type PTENY155C; PIK3CAR38C; AKT2V198A SKOV3 Wild-type ERBB2 amplification; PIK3CAH1047R CAOV3 Wild-type PTENW274G OVCAR4 Wild-type Cell lines with low MECP2: OVCAR3 Wild-type CCNE1 amplification; AKT2 amplification OVCAR5 KRASG12V OVCAR8 KRASP121H ERBB2G776V .
Load more

Recommended publications
  • Genetic Analysis of Retinopathy in Type 1 Diabetes
    Genetic Analysis of Retinopathy in Type 1 Diabetes by Sayed Mohsen Hosseini A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Institute of Medical Science University of Toronto © Copyright by S. Mohsen Hosseini 2014 Genetic Analysis of Retinopathy in Type 1 Diabetes Sayed Mohsen Hosseini Doctor of Philosophy Institute of Medical Science University of Toronto 2014 Abstract Diabetic retinopathy (DR) is a leading cause of blindness worldwide. Several lines of evidence suggest a genetic contribution to the risk of DR; however, no genetic variant has shown convincing association with DR in genome-wide association studies (GWAS). To identify common polymorphisms associated with DR, meta-GWAS were performed in three type 1 diabetes cohorts of White subjects: Diabetes Complications and Control Trial (DCCT, n=1304), Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR, n=603) and Renin-Angiotensin System Study (RASS, n=239). Severe (SDR) and mild (MDR) retinopathy outcomes were defined based on repeated fundus photographs in each study graded for retinopathy severity on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Multivariable models accounted for glycemia (measured by A1C), diabetes duration and other relevant covariates in the association analyses of additive genotypes with SDR and MDR. Fixed-effects meta- analysis was used to combine the results of GWAS performed separately in WESDR, ii RASS and subgroups of DCCT, defined by cohort and treatment group. Top association signals were prioritized for replication, based on previous supporting knowledge from the literature, followed by replication in three independent white T1D studies: Genesis-GeneDiab (n=502), Steno (n=936) and FinnDiane (n=2194).
    [Show full text]
  • Identification of a Novel CHN1 P.(Phe213val) Variant in a Large Han Chinese Family with Congenital Duane Retraction Syndrome
    www.nature.com/scientificreports OPEN Identifcation of a novel CHN1 p.(Phe213Val) variant in a large Han Chinese family with congenital Duane retraction syndrome Tai‑Cheng Zhou1,3, Wen‑Hua Duan1,3, Xiao‑Lin Fu2,3, Qin Zhu1, Li‑Yun Guo1, Yuan Zhou1, Zhi‑Juan Hua1, Xue‑Jiao Li1, Dong‑Mei Yang1, Jie‑Ying Zhang1, Jie Yin1, Xiao‑Fan Zhang1, Guang‑Long Zhou1 & Min Hu1* Duane retraction syndrome (DRS) is a neuromuscular dysfunction of the eyes. Although many causative genes of DRS have been identifed in Europe and the United States, few reports have been published in regard to Chinese DRS. The aim of the present study was to explore the genetic defect of DRS in a Chinese family. Exome sequencing was used to identify the disease‑causing gene for the two afected family members. Ophthalmic and physical examinations, as well as genetic screenings for variants in chimerin 1 (CHN1), were performed for all family members. Functional analyses of a CHN1 variant in 293T cells included a Rac‑GTP activation assay, α2‑chimaerin translocation assay, and co‑immunoprecipitation assay. Genetic analysis revealed a NM_001822.7: c.637T > G variant in the CHN1 gene, which resulted in the substitution of a highly conserved C1 domain with valine at codon 213 (NP_001813.1: p.(Phe213Val)) (ClinVar Accession Number: SCV001335305). In-silico analysis revealed that the p.(Phe213Val) substitution afected the protein stability and connections among the amino acids of CHN1 in terms of its tertiary protein structure. Functional studies indicated that the p.(Phe213Val) substitution reduced Rac‑GTP activity and enhanced membrane translocation in response to phorbol‑myristoyl acetate (PMA).
    [Show full text]
  • A Cell Line P53 Mutation Type UM
    A Cell line p53 mutation Type UM-SCC 1 wt UM-SCC5 Exon 5, 157 GTC --> TTC Missense mutation by transversion (Valine --> Phenylalanine UM-SCC6 wt UM-SCC9 wt UM-SCC11A wt UM-SCC11B Exon 7, 242 TGC --> TCC Missense mutation by transversion (Cysteine --> Serine) UM-SCC22A Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC22B Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC38 Exon 5, 132 AAG --> AAT Missense mutation by transversion (Lysine --> Asparagine) UM-SCC46 Exon 8, 278 CCT --> CGT Missense mutation by transversion (Proline --> Alanine) B 1 Supplementary Methods Cell Lines and Cell Culture A panel of ten established HNSCC cell lines from the University of Michigan series (UM-SCC) was obtained from Dr. T. E. Carey at the University of Michigan, Ann Arbor, MI. The UM-SCC cell lines were derived from eight patients with SCC of the upper aerodigestive tract (supplemental Table 1). Patient age at tumor diagnosis ranged from 37 to 72 years. The cell lines selected were obtained from patients with stage I-IV tumors, distributed among oral, pharyngeal and laryngeal sites. All the patients had aggressive disease, with early recurrence and death within two years of therapy. Cell lines established from single isolates of a patient specimen are designated by a numeric designation, and where isolates from two time points or anatomical sites were obtained, the designation includes an alphabetical suffix (i.e., "A" or "B"). The cell lines were maintained in Eagle's minimal essential media supplemented with 10% fetal bovine serum and penicillin/streptomycin.
    [Show full text]
  • Two Locus Inheritance of Non-Syndromic Midline Craniosynostosis Via Rare SMAD6 and 4 Common BMP2 Alleles 5 6 Andrew T
    1 2 3 Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and 4 common BMP2 alleles 5 6 Andrew T. Timberlake1-3, Jungmin Choi1,2, Samir Zaidi1,2, Qiongshi Lu4, Carol Nelson- 7 Williams1,2, Eric D. Brooks3, Kaya Bilguvar1,5, Irina Tikhonova5, Shrikant Mane1,5, Jenny F. 8 Yang3, Rajendra Sawh-Martinez3, Sarah Persing3, Elizabeth G. Zellner3, Erin Loring1,2,5, Carolyn 9 Chuang3, Amy Galm6, Peter W. Hashim3, Derek M. Steinbacher3, Michael L. DiLuna7, Charles 10 C. Duncan7, Kevin A. Pelphrey8, Hongyu Zhao4, John A. Persing3, Richard P. Lifton1,2,5,9 11 12 1Department of Genetics, Yale University School of Medicine, New Haven, CT, USA 13 2Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA 14 3Section of Plastic and Reconstructive Surgery, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA 15 4Department of Biostatistics, Yale University School of Medicine, New Haven, CT, USA 16 5Yale Center for Genome Analysis, New Haven, CT, USA 17 6Craniosynostosis and Positional Plagiocephaly Support, New York, NY, USA 18 7Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA 19 8Child Study Center, Yale University School of Medicine, New Haven, CT, USA 20 9The Rockefeller University, New York, NY, USA 21 22 ABSTRACT 23 Premature fusion of the cranial sutures (craniosynostosis), affecting 1 in 2,000 24 newborns, is treated surgically in infancy to prevent adverse neurologic outcomes. To 25 identify mutations contributing to common non-syndromic midline (sagittal and metopic) 26 craniosynostosis, we performed exome sequencing of 132 parent-offspring trios and 59 27 additional probands.
    [Show full text]
  • Environmental Influences on Endothelial Gene Expression
    ENDOTHELIAL CELL GENE EXPRESSION John Matthew Jeff Herbert Supervisors: Prof. Roy Bicknell and Dr. Victoria Heath PhD thesis University of Birmingham August 2012 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Tumour angiogenesis is a vital process in the pathology of tumour development and metastasis. Targeting markers of tumour endothelium provide a means of targeted destruction of a tumours oxygen and nutrient supply via destruction of tumour vasculature, which in turn ultimately leads to beneficial consequences to patients. Although current anti -angiogenic and vascular targeting strategies help patients, more potently in combination with chemo therapy, there is still a need for more tumour endothelial marker discoveries as current treatments have cardiovascular and other side effects. For the first time, the analyses of in-vivo biotinylation of an embryonic system is performed to obtain putative vascular targets. Also for the first time, deep sequencing is applied to freshly isolated tumour and normal endothelial cells from lung, colon and bladder tissues for the identification of pan-vascular-targets. Integration of the proteomic, deep sequencing, public cDNA libraries and microarrays, delivers 5,892 putative vascular targets to the science community.
    [Show full text]
  • HIST1H2BN (H2BC15) (NM 003520) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC224109L3 HIST1H2BN (H2BC15) (NM_003520) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: HIST1H2BN (H2BC15) (NM_003520) Human Tagged ORF Clone Tag: Myc-DDK Symbol: H2BC15 Synonyms: H2B/d; H2BFD; HIST1H2BN Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC224109). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_003520 ORF Size: 378 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 HIST1H2BN (H2BC15) (NM_003520) Human Tagged ORF Clone – RC224109L3 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_003520.3 RefSeq Size: 449 bp RefSeq ORF: 381 bp Locus ID: 8341 UniProt ID: Q99877, A0A024RCJ9 Protein Pathways: Systemic lupus erythematosus MW: 13.9 kDa Gene Summary: Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes.
    [Show full text]
  • Missense Variant in LOXHD1 Is Associated with Canine Nonsyndromic Hearing Loss
    Missense Variant in LOXHD1 is Associated With Canine Nonsyndromic Hearing Loss Marjo K Hytönen University of Helsinki: Helsingin Yliopisto Julia E Niskanen University of Helsinki: Helsingin Yliopisto Meharji Arumilli University of Helsinki: Helsingin Yliopisto Casey A Knox Wisdom Health Jonas Donner Genoscoper Laboratories Hannes Lohi ( hannes.lohi@helsinki. ) Helsingin Yliopisto Laaketieteellinen tiedekunta https://orcid.org/0000-0003-1087-5532 Research Article Keywords: dog, hearing, hearing loss, deafness, Rottweiler, stereocilia, PLAT Posted Date: March 16th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-288479/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/16 Abstract Hearing loss is a common sensory decit both in humans and dogs. In canines the genetic basis is largely unknown, as genetic variants have only been identied for a syndromic form of hearing impairment. We observed a congenital or early-onset sensorineural hearing loss in a Rottweiler litter. Assuming an autosomal recessive inheritance, we used a combined approach of homozygosity mapping and genome sequencing to dissect the genetic background of the disorder. We identied a fully segregating missense variant in LOXHD1, a gene that is known to be essential for cochlear hair cell function and associated with nonsyndromic hearing loss in humans and mice. The canine LOXHD1 variant was specic to the Rottweiler breed in our study cohorts of pure-bred dogs. However, it also was present in mixed-breed dogs, of which the majority showed Rottweiler ancestry. Low allele frequencies in these populations, 2.6 % and 0.04 %, respectively, indicate a rare variant.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Neuronal and Glial DNA Methylation and Gene Expression Changes in Early Epileptogenesis
    RESEARCH ARTICLE Neuronal and glial DNA methylation and gene expression changes in early epileptogenesis 1,2☯ 3☯ 3 4,5 Toni C. BergerID *, Magnus D. Vigeland , Hanne S. Hjorthaug , Lars Etholm , Cecilie G. Nome2, Erik Taubøll1,2, Kjell Heuser1,2³, Kaja K. Selmer3,4,6³ 1 Department of Neurology, Oslo University Hospital, Oslo, Norway, 2 University of Oslo, Oslo, Norway, 3 Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway, 4 National Center for Epilepsy, Oslo University Hospital, Sandvika, Norway, 5 Department of Neurology, Section for Neurophysiology, Oslo University Hospital, Oslo, Norway, 6 Division of Clinical Neuroscience, Department of Research and Development, Oslo University Hospital, Oslo, Norway a1111111111 ☯ These authors contributed equally to this work. a1111111111 ³ KH and KKS also contributed equally to this work. a1111111111 * [email protected] a1111111111 a1111111111 Abstract Background and aims OPEN ACCESS Mesial Temporal Lobe Epilepsy is characterized by progressive changes of both neurons Citation: Berger TC, Vigeland MD, Hjorthaug HS, Etholm L, Nome CG, Taubøll E, et al. (2019) and glia, also referred to as epileptogenesis. No curative treatment options, apart from sur- Neuronal and glial DNA methylation and gene gery, are available. DNA methylation (DNAm) is a potential upstream mechanism in epilep- expression changes in early epileptogenesis. PLoS togenesis and may serve as a novel therapeutic target. To our knowledge, this is the first ONE 14(12): e0226575. https://doi.org/10.1371/ study to investigate epilepsy-related DNAm, gene expression (GE) and their relationship, in journal.pone.0226575 neurons and glia. Editor: Giuseppe Biagini, University of Modena and Reggio Emilia, ITALY Methods Received: July 18, 2019 We used the intracortical kainic acid injection model to elicit status epilepticus.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]